IBL C1Q-CIC CIA TEST— 510(k) K032254
Substantially EquivalentIbl GmbH
FDA 510(k) clearance K032254 for IBL C1Q-CIC CIA TEST, Substantially Equivalent on 2003-08-29. Applicant: Ibl GmbH. Device class: 2.
Clearance details
- Applicant
- Ibl GmbH
- Product code
- Code DAK
- Device class
- Class 2
- Regulation
- 21 CFR 866.5240
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- East Stroudsburg, PA, US
Recent devices under product code DAK
view allMore clearances from Ibl GmbH
view all- K051969 — TRICAT RIA (ADRENALIN/NORADRENALIN/DOPAMINE); KATCOMBI RIA (ADRENALIN/NORADRENALIN); NORADRENALIN RIA
- K041349 — LUMINESCENT IMMUNOASSAY KIT FOR THE DETECTION OF ESTRADIOL IN SALIVA AND SERUM
- K040923 — LUMINESCENT IMMUNOASSAY KIT FOR THE DETECTION OF PROGESTERONE IN SALIVA
- K033786 — LUMINESCENT IMMUNOASSAY KIT FOR THE DETECTION OF TESTOSTERONE IN SERUM AND SALIVA
- K032796 — IBL C3D-CIC EIA TEST
Data sourced from openFDA. This site is unofficial and independent of the FDA.